CNS Response: The key to informed mental health treatment

Not finding the mental health solution you need?

Who is rEEG® For?

Patient Benefit:
rEEG® has frequently been used for treatment-resistant mental disorders, in which patients have
failed to respond to previous medications.  With rEEG®, treatment is guided by physiological measures of the brain, not simply patient symptoms.  This often leads physicians  to more effective treatments in less time, with fewer treatment failures.

Physician Benefit:
Today, physicians are trying their best to treat arguably the most complicated of disorders, in the most advanced function (behavior and emotion) of the most highly developed organ in the body (the brain), with some of the most powerful medications ever developed based on patient observation, interviews and history. That's it. Psychiatrists don't get an EKG or a blood test, their data is a conversation! This task is as challenging as any in medicine.

Some patients achieve remission in this process. Many others do not. Sometimes these patients need special unscheduled attention that can put the clinician on call 24/7; other times the patient feels compelled to seek out alternative or additional medical help. Everyone involved would like to be more successful. Physicians have reported that the simple rEEG® report provides help in approximately 75% of their most challenging cases.

Payers Benefit:
The fact of the matter is that failed treatment efforts are not only disappointing to the patient, family and clinicians, but are costly. Someone always has to pay the healthcare bill. Inefficient treatment is costly. Ineffective treatment is costly. In fact, it is estimated by some that 10% of the behavioral disorder patients account for 40% of the total costs of behavioral care. rEEG®changes this equation dramatically.

Pharmaceutical Developers Benefit:
Development of new medications is also extremely costly. Determining who will benefit from a new medication is costly, usually inefficient, and sometimes never completely understood. rEEG®benefits developers of new therapies in many ways including:

  • Identifying patient populations that will respond well to their medication when previous clinical trial efforts have failed to show success
  • Identifying new uses of medications previously approved
  • Identifying synergistic relationships between combinations of medications
  • Designing clinical trials
  • Understanding dose response of new meds